Cognitive Disorders More Common in People Admitted for COVID-19
Jingqi Zhou, Ph.D., from the University of Georgia in Athens, and colleagues examined the association of COVID-19 with 974 medical conditions and 30 blood biomarkers using data from 1,091 participants in the U.K. Biobank who tested positive for COVID-19.
The researchers found that the most significant risk factors for COVID-19 include Alzheimer disease (odds ratio, 2.29), dementia (odds ratio, 2.16), and the overall category of delirium, dementia, and amnestic and other cognitive disorders (odds ratio, 1.90). There were associations seen between genetic variants in severe acute respiratory syndrome coronavirus 2 infection-related genes and COVID-19 (odds ratio, 1.33) and other phenotypes, including immune deficiency and prostate cancer.
"Our unbiased phenome-wide study in [the] U.K. Biobank confirmed known and identified novel risk factors for COVID-19, including dementia, Alzheimer's disease, type 2 diabetes, blood biomarkers of cardiovascular health, and genetic variants in TMPRSS2," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...
FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...
THURSDAY, Jan. 21, 2021 -- Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.